CHUCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Charlie's Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026
$0.11+0.01 (+13.30%)
Close on Oct 19, 2026
- Market cap
- $31.05M
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
27.0%−28.2 pts over 5 years
Operating margin
-10.4%+30.2 pts over 5 years
Net margin
21.5%+64.6 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +169.4% | -7.5% | +4.6% | +13.1% | |
| Gross profit | +96.6% | – | -9.3% | – |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 394.3% | 219.7% | 547.7% | |
| Return on assets | -80.3% | -100.0% | 58.0% | |
| Current ratio | 0.14 | 0.44 | 1.41 | |
| Debt to equity | – | -0.17 | – | |
| Net debt to EBITDA | – | 0.06× | – | |
| Interest coverage | -208.3× | -50.5× | -3.1× | |
| Inventory turnover | 2.4× | 4.8× | 3.4× | |
| Capex to revenue | 0.5% | 1.0% | 0.1% | |
| Diluted shares | 1M | 190M | 279M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Charlie's generated $11.25M from operations and spent $1.21M on capital expenditure, dividends and share buybacks. 27% of that went back into the business.
Generated
$11.25M
Used
$1.21M
Capital expenditure$322.00K27%Dividends$883.00K73%Share buybacks$00%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin21.5%
×Asset turnover2.70×
×Equity multiplier9.44×
=Return on equity, FY2025547.7%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 21.5% | 2.70× | 9.44× | 547.7% |
| FY2024 | -53.6% | 1.60× | -5.15× | 440.8% |
| FY2023 | -12.9% | 2.53× | 8.05× | -262.8% |
| FY2022 | -6.0% | 3.24× | 3.38× | -65.9% |
| FY2021 | 22.4% | 2.73× | -5.51× | -335.6% |
| FY2020 | -43.1% | 2.32× | -2.20× | 219.7% |
| FY2019 | -9.4% | 4.53× | 41.13× | -1759.0% |
| FY2018 | 34.5% | 5.91× | 3.02× | 617.0% |
| FY2017 | -325.6% | 0.78× | -14.56× | 3693.1% |
| FY2016 | -211.4% | 0.38× | -4.91× | 394.3% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
4of 8 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero$4.50M
- Cash generatingOperating cash flow above zero-$5.78M
- Return on assets improvedROA up on the prior year-72.1% → 114.0%
- Earnings backed by cashOperating cash flow above net income-$5.78M vs $4.50M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose0.67 → 1.41
- No dilutionShare count did not rise235M → 279M
- Gross margin improvedGross margin up on the prior year37.05% → 27.04%
- More efficientAsset turnover rose1.35 → 5.30